SEC Form 4 · accession 0001104659-15-027094
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marilyn J. Purchase
Officer — Corp. Exec. VP of Operations
Period of report
Apr 9, 2015
Accepted (ET)
Apr 10, 2015 · 7:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 9, 2015 | M | 28,000 | $14.80 | A | 72,902 | D | |
| Common Stock | Apr 9, 2015 | S | 28,000 | $15.79 | D | 44,902 | D | |
| Common StockF2 | holding | — | — | — | 16,044 | I | See footnote. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $14.80 | Apr 9, 2015 | M | 28,000 | D | — | May 15, 2015 | Common Stock | 28,000 | 0 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2014.
- F2The shares are held directly by the Purchase Family Trust for which the Reporting Person serves as co-trustee.
- F3Shares subject to the option are fully vested and immediately exercisable.